United and Aon join forces
Aon Corporation (NYSE:AON), the world’s leading risk advisor and human capital consultant, has kicked off its four-year shirt sponsorship of Manchester United with a programme of global charity initiatives designed to promote youth development and healthier communities.
The sponsorship and charity campaign were launched at Old Trafford this morning by executives of Aon and Manchester United, alongside club legends Sir Bobby Charlton, Bryan Robson and Quinton Fortune.
"Based on our shared values of leadership, teamwork and a passion for excellence, it is difficult to imagine a stronger fit for Aon than Manchester United," said Aon Corporation president and chief executive Greg Case. "Through the global charitable initiatives of Aon’s 36,000 colleagues, we will work with our partners at Manchester United and the Manchester United Foundation to promote these values and create positive opportunities for young people, to enable them to thrive and to help improve their communities."
United chief executive officer David Gill said: "This event is an indication of how Aon is committed to developing the partnership way beyond a simple commercial arrangement. In the coming years, I hope we will be able to build a tangible legacy for the Manchester United community both here in the north west and further afield. I am delighted Aon wants to get its whole worldwide workforce involved. I'm sure it will really bring the sponsorship to life for many of them."
To mark the start of the sponsorship, the first charity event involved more than 150 of Aon’s Manchester-based colleagues and their families. They participated in a penalty shootout challenge at Old Trafford for the Manchester-based The Christie charity, a leading cancer centre that treats more than 40,000 patients a year.
The Aon Foundation donated £25,000, of which £3,500 came from the penalty challenge, to The Survivorship Programme of The Christie, which helps young people progress in their educational and career goals and receive life skills and support following cancer treatment.